Reported 0 shares, down 32,913 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2022-06-30 | 6605 |
| 2022-09-30 | 5442 |
| 2022-12-31 | 3877 |
| 2023-03-31 | 3547 |
| 2023-06-30 | 0 |
| 2024-06-30 | 1198 |
| 2024-09-30 | 18853 |
| 2024-12-31 | 0 |
| 2025-12-31 | 12763 |
| 2026-03-31 | 5352 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -32,913 (-100.0%) | 0 | $0 | 2026-07-29 | |
| Q1 2026 | Added | 32,913 | +8,000 (32.1%) | < 0.01% | $5,352 | 2026-05-11 | |
| Q4 2025 | New | 24,913 | +24,913 (0.0%) | < 0.01% | $12,763 | 2026-01-29 | |
| Q4 2024 | Reduced | 0 | -12,913 (-100.0%) | 0 | $0 | 2025-02-07 | |
| Q3 2024 | Added | 12,913 | +12,098 (1484.4%) | < 0.01% | $18,853 | 2024-11-05 | |
| Q2 2024 | New | 815 | +815 (0.0%) | < 0.01% | $1,198 | 2024-08-07 | |
| Q2 2023 | Reduced | 0 | -12,230 (-100.0%) | 0 | $0 | 2024-04-23 | |
| Q1 2023 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $3,547 | 2024-04-23 | |
| Q4 2022 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $3,877 | 2024-04-22 | |
| Q3 2022 | Unchanged | 12,230 | 0 (0.0%) | < 0.01% | $5,442 | 2024-04-22 | |
| Q2 2022 | New | 12,230 | +12,230 (0.0%) | < 0.01% | $6,605 | 2024-04-22 |
Who else reported the position
24 managers reported PLUS THERAPEUTICS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Cambridge Investment Research Advisors Inc | Reduced | 0 | -13,450 | 0 | $0 | 4 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -133 | 0 | $0 | 13 qtrs |
| DAGCO Inc | Reduced | 0 | -25,882 | 0 | $0 | 4 qtrs |
| Citigroup Inc | Reduced | 0 | -93,002 | 0 | $0 | 3 qtrs |
| Kestra Advisory Services LLC | Reduced | 0 | -25,800 | 0 | $0 | 4 qtrs |
| Barclays PLC | Reduced | 0 | -2 | 0 | $0 | 2 qtrs |
| Sound Income Strategies LLC | Reduced | 0 | -28 | 0 | $0 | 3 qtrs |
| XTX Topco Ltd | Reduced | 0 | -116,023 | 0 | $0 | 3 qtrs |
| BlackRock Inc | Reduced | 0 | -1,776,372 | 0 | $0 | 8 qtrs |
| MILLENNIUM MANAGEMENT LLC | Reduced | 0 | -271,599 | 0 | $0 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- July 29, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.